InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: King Stuki post# 203

Tuesday, 03/16/2004 11:26:16 AM

Tuesday, March 16, 2004 11:26:16 AM

Post# of 27550
Stewart,

Good to see you here!

DCTH is having a strong day again today. There should be more frequent news from the company as they expand their PIII trial to new hospitals. I would have to believe that institutions have been behind the recent strength in DCTH. Legg Mason and Fleet Boston had small positions of about 5k at the end of 2003, hopefully they're increasing their positions now? What would really set DCTH off is a partnership with a large, established medical device company (BSX, MDT, etc.). Hopefully this will come eventually.

BIPH is currently in a quiet period, awaiting SEC approval of a registration statement filed Feb. 25th, which should be complete soon. I'm looking to accumulate more BIPH before the quiet period ends. Medtronic said in an investor presentation they intend to have a MRI-compatible pacemaker by 2005. BIPH said in an SEC filing they have been presented with an offer for "exclusive-liscensing" of their pacemaker technology. I speculate that there is a connection here....and the registration statement could possibly be a factor too? It's just speculation; but there's some strong relationships here IMO.

I have no experience with ADL. From a quick look, nothing is jumping out at me there. The financing on January 12, below the market price is a little discouraging to me. I don't see nay major distribution or research partners on their website....these are the things I look for on speculative med. device and pharmaceutical plays. Still could be a good play; but I'm not sure what diferentiates it.


"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.